- 期刊
Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients
延伸閱讀
- Anazi, K. A. A. (2012). Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation. Bone Marrow Research, 2012(), 242-248. https://doi.org/10.1155/2012/917361
- Tsai, H. J., Lin, S. F., Liu, T. C., Chang, C. S., Hsiao, H. H., & Chen, T. P. (2004). Pure Red Cell Aplasia After ABO Major-mismatched Allogeneic Peripheral Blood Stem Cell Transplantation Successfully Treated with Plasma Exchange and Low-dose Steroid :Two Case Reports. The Kaohsiung Journal of Medical Sciences, 20(3), 128-132. https://www.airitilibrary.com/Article/Detail?DocID=02575655-200403-20-3-128-132-a
- 洪惠青、張正雄、鍾智淵（2003）。Collection and Cryopreservation of Autologous Peripheral Blood Stem Cells and its Application in Autologous Peripheral Blood Stem Cells。The Changhua Journal of Medicine，8(3)，155-160。https://www.airitilibrary.com/Article/Detail?DocID=16801504-200307-8-3-155-160-a
- 葉淑婷、李金德、卓士峯（2022）。Analysis of Medical Resource Consumption in Multiple Myeloma Patients Who Received Autologous Hematopoietic Stem Cell Transplantation。秀傳醫學雜誌，21(1)，25-34。https://doi.org/10.53106/156104972022062101004
- Zeng, T., Zhou, L., Xi, H., Fu, W., Du, J., Zhang, C., Jiang, H., & Hou, J. (2015). Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy. Stem Cells International, 2015(), 9-15-101. https://doi.org/10.1155/2015/613045